Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation
Open Access
- 1 May 2010
- journal article
- case report
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 5 (5) , 421-426
Abstract
The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF). The current recommendation for pharmacological treatment of this condition is amiodarone. A review of the past 25 years of literature finds several studies that identify a small risk of ventricular fibrillation secondary to amiodarone administration for rate control in WPW-AF. Additionally, the literature supports the safe and effective use of procainamide for rate control in WPW-AF. This review concludes that amiodarone is not superior to procainamide in rate control for WPW-AF, and may be dangerous.Keywords
This publication has 13 references indexed in Scilit:
- Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the EDThe American Journal of Emergency Medicine, 2007
- Amiodarone Is Poorly Effective for the Acute Termination of Ventricular TachycardiaAnnals of Emergency Medicine, 2006
- The Quest for a TerminatorAnnals of Emergency Medicine, 2006
- Myth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff–Parkinson–White syndrome in the emergency departmentCanadian Journal of Emergency Medicine, 2005
- Management of Patients With Atrial FibrillationCirculation, 1996
- [Electrophysiological properties of atrial fibrillation with WPW syndrome and the role of procainamide in conversion].1991
- Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.Heart, 1989
- Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case reportInternational Journal of Cardiology, 1987
- Wolff-Parkinson-White syndrome presenting in atrial fibrillationAnnals of Emergency Medicine, 1987
- Efficacy of amiodarone in the wolff-parkinson-white syndrome with rapid ventricular response via accessory pathway during atrial fibrillationThe American Journal of Cardiology, 1984